Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)

PHASE1CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 7, 2019

Primary Completion Date

May 30, 2021

Study Completion Date

July 25, 2021

Conditions
Hepatitis B
Interventions
BIOLOGICAL

One dose of investigational vaccine

One dose of investigational hepatitis B vaccine (10μg/0.5ml) developed by Sinovac Research \& Development Co., Ltd.

BIOLOGICAL

One dose of control vaccine

One dose of control hepatitis B vaccine (10μg/0.5ml) manufactured by Dalian Hissen Bio-pharmInc.

BIOLOGICAL

Three doses of investigational vaccine

Three doses of investigational hepatitis B vaccine (10μg/0.5ml) developed by Sinovac Research \& Development Co., Ltd. on the schedule of month 0,1,2

BIOLOGICAL

Three doses of control vaccine

Three doses of control hepatitis B vaccine (10μg/0.5ml) manufactured by Dalian Hissen Bio-pharmInc.

Trial Locations (1)

463700

Biyang County Center for Disease Control and Prevention, Zhumadian

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT04075201 - Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) | Biotech Hunter | Biotech Hunter